Sarmaya Thematic ETF
LENS
3 hedge funds and large institutions have $509K invested in Sarmaya Thematic ETF in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
0% more capital invested
Capital invested by funds: $508K → $509K (+$1.68K)
3.68% less ownership
Funds ownership: 14.44% → 10.77% (-3.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SEA
Stegent Equity Advisors
Houston,
Texas
|
+$289K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$197K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MASUI
MIRAE ASSET SECURITIES (USA) INC.
New York
|
-$508K |
LENS Hedge Fund Activity: Q2 2025 in Review
3 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Sarmaya Thematic ETF (LENS) for Q2 2025, worth a combined $509K — up 0.33% from $508K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new LENS positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Stegent Equity Advisors, opening a new position worth an estimated $289K. The largest seller was MIRAE ASSET SECURITIES (USA) INC., exiting entirely with an estimated $508K sold.
- 3 institutional investors held Sarmaya Thematic ETF (LENS) as of Q2 2025, up from 1 in Q1 2025.
- Funds reported $509K of Sarmaya Thematic ETF stock for Q2 2025, up 0.33% quarter-over-quarter.
- 3 funds opened new Sarmaya Thematic ETF positions in Q2 2025 and 1 closed out, a net change of +2 holders.
- The largest Sarmaya Thematic ETF buyer in Q2 2025 was Stegent Equity Advisors, an estimated $289K added.
- The largest Sarmaya Thematic ETF seller in Q2 2025 was MIRAE ASSET SECURITIES (USA) INC., an estimated $508K sold.
Based on aggregated 13F filings for Q2 2025.